Cardinal Health Future Growth

Future criteria checks 3/6

Cardinal Health is forecast to grow earnings and revenue by 16.2% and 5.5% per annum respectively. EPS is expected to grow by 17.9% per annum. Return on equity is forecast to be 577.2% in 3 years.

Key information

16.2%

Earnings growth rate

17.9%

EPS growth rate

Healthcare earnings growth16.1%
Revenue growth rate5.5%
Future return on equity577.2%
Analyst coverage

Good

Last updated23 Apr 2024

Recent future growth updates

Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Feb 03
Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Recent updates

Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk

Apr 14
Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk

Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?

Mar 09
Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?

Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration

Feb 20

Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Feb 03
Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues

Dec 28
Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues

Cardinal Health Is Setting Up For A Great 2024

Dec 21

Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Nov 03
Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity

Oct 13

Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation

Aug 07

Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue

Aug 05
Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue

An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued

Jul 14
An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued

Cardinal Health: Not A Long-Term Investment

May 24

The Return Trends At Cardinal Health (NYSE:CAH) Look Promising

Apr 17
The Return Trends At Cardinal Health (NYSE:CAH) Look Promising

Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price

Mar 30
Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price

Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)

Feb 21

Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957

Feb 16
Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957

Cardinal Health declares $0.4957 dividend

Feb 10

Cardinal Health FQ2 2023 Earnings Preview

Feb 01

Cardinal Health partners with Palantir for data-driven supply chain support

Jan 26

Cardinal Health Is A Tempting Healthcare Income Play

Dec 28

Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957

Dec 20
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957

Aaron Alt is the new finance chief at Cardinal health

Dec 19

Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?

Dec 14
Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?

Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Nov 16
Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment

Nov 14

Cardinal Health rises on Q1 earnings beat

Nov 04

Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term

Oct 10

Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Sep 29
Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957

Cardinal Health: Aristocrat Heading For A Makeover

Sep 26

PayrHealth to collaborate with Cardinal Health

Sep 15

Cardinal Health in pact with activist investor Elliot for value creation measures

Sep 06

Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957

Sep 01
Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957

Activist interest in Cardinal Health could unlock value, improve margins - Morgan Stanley

Aug 16

Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?

Aug 15
Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?

Cardinal Health Q4 2022 Earnings Preview

Aug 10

Cardinal Health appoints Michelle Greene as CIO

Aug 01

Cardinal Health: Little Price Appreciation Potential But Covered Calls Are Worth Considering

Jul 22

Earnings and Revenue Growth Forecasts

NYSE:CAH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2026255,7751,6892,1632,58513
6/30/2025238,6901,5452,0122,35115
6/30/2024226,2831,2102,1282,61715
12/31/2023216,1486393,4213,953N/A
9/30/2023210,1721562,8583,361N/A
6/30/2023205,0122612,3582,839N/A
3/31/2023198,6624634,5454,973N/A
12/31/2022193,011-1,2732,7923,193N/A
9/30/2022186,999-1,0943,4013,791N/A
6/30/2022181,364-9332,7353,122N/A
3/31/2022176,847-955446795N/A
12/31/2021171,2865551,1241,491N/A
9/30/2021167,3701,1351,1241,513N/A
6/30/2021162,4676112,0292,429N/A
3/31/2021156,5701,1511,5942,004N/A
12/31/2020156,4521,3823,0033,403N/A
9/30/2020154,6469732,5022,883N/A
6/30/2020152,922-3,6961,5851,960N/A
3/31/2020153,586-4,1581,8512,226N/A
12/31/2019149,657-4,2121,6692,030N/A
9/30/2019147,662-4,1521,3621,704N/A
6/30/2019145,5341,3632,3942,722N/A
3/31/2019143,53032,4402,770N/A
12/31/2018141,935-391,7122,044N/A
9/30/2018139,3817341,5771,952N/A
6/30/2018136,8092562,3842,768N/A
3/31/2018134,4261,6962,5982,938N/A
12/31/2017132,6141,8231,6441,986N/A
9/30/2017130,5781,094N/A2,261N/A
6/30/2017129,9761,288N/A1,184N/A
3/31/2017128,3941,346N/A1,101N/A
12/31/2016127,2361,351N/A2,218N/A
9/30/2016125,5301,353N/A3,127N/A
6/30/2016121,5461,427N/A2,971N/A
3/31/2016117,7101,387N/A3,198N/A
12/31/2015112,4231,366N/A2,937N/A
9/30/2015106,5161,329N/A2,427N/A
6/30/2015102,5311,212N/A2,540N/A
3/31/201597,8771,154N/A2,388N/A
12/31/201493,9281,104N/A2,550N/A
9/30/201490,6311,089N/A1,634N/A
6/30/201491,0841,163N/A2,524N/A
3/31/201493,610343N/A2,108N/A
12/31/201396,735374N/A2,277N/A
9/30/201399,727403N/A2,110N/A
6/30/2013101,093335N/A1,727N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CAH's forecast earnings growth (16.2% per year) is above the savings rate (2.3%).

Earnings vs Market: CAH's earnings (16.2% per year) are forecast to grow faster than the US market (14.6% per year).

High Growth Earnings: CAH's earnings are forecast to grow, but not significantly.

Revenue vs Market: CAH's revenue (5.5% per year) is forecast to grow slower than the US market (8% per year).

High Growth Revenue: CAH's revenue (5.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CAH's Return on Equity is forecast to be very high in 3 years time (577.2%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.